Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype

BACKGROUND: We analyzed the responses to first line treatment and clinical outcomes of metastatic breast cancer patients treated with palliative doxorubicin/cyclophosphamide (AC) according to molecular cancer subtype. METHODS: A retrospective analysis was performed for 110 metastatic breast cancer p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yi, Seong Yoon, Ahn, Jin Seok, Uhm, Ji Eun, Lim, Do Hyoung, Ji, Sang Hoon, Jun, Hyun Jung, Kim, Kyoung Ha, Chang, Myung Hee, Park, Min Jae, Cho, Eun Yoon, La Choi, Yoon, Park, Yeon Hee, Im, Young-Hyuck
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2010
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2972282/
https://ncbi.nlm.nih.gov/pubmed/20920367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-527
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge